Dr Naomi Clay, OD in Manchester, NH - Medicare Optometry Provider

Dr Naomi Clay, OD is a medicare enrolled "Optometrist" provider in Manchester, New Hampshire. She graduated from medical school in 2016 and has 8 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Aeg Massachusetts Professional Pc and her current practice location is 2075 S Willow St, Manchester, New Hampshire. You can reach out to her office (for appointments etc.) via phone at (603) 644-6100.

Dr Naomi Clay is licensed to practice in New Hampshire (license number 0923) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1225585524.

Contact Information

	Dr Naomi Clay, OD
	2075 S Willow St, Manchester, NH 03103-2305
	(603) 644-6100
	Not Available

Healthcare Provider's Profile

Full Name	Dr Naomi Clay
Gender	Female
Speciality	Optometry
Experience	8 Years
Location	2075 S Willow St, Manchester, New Hampshire
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Naomi Clay graduated from medical school in 2016

NPI Data:

NPI Number: 1225585524
Provider Enumeration Date: 09/02/2016
Last Update Date: 09/02/2016

Medicare PECOS Information:

PECOS PAC ID: 7214201599
Enrollment ID: I20170926000777

Medical Identifiers

Medical identifiers for Dr Naomi Clay such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1225585524	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	0923 (New Hampshire)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Aeg Massachusetts Professional Pc	6901282557	26

News Archive

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

By designing a molecular bridge, scientists at the University of Illinois at Urbana-Champaign have forged a successful pathway through a complex ocean of barriers: They've changed the function of a protein using a co-evolution approach.

Metamark Genetics closes $22M Series B financing

Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million Series B financing. Metamark's Prognosis Determinants platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal translational and commercialization efforts to bring these breakthrough discoveries to cancer patients worldwide.

Advocacy groups unite to make lung cancer in women a top priority

Women's health and lung cancer advocacy groups, led by the Society for Women's Health Research, vowed today to make lung cancer education and advocacy, especially among women, a top priority for their organizations in 2006 and beyond.

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Hanger Orthopedic Group, Inc. today announced the completion of enrollment in its pivotal INSTRIDE investigational device exemption (IDE) clinical trial studying the effectiveness of its WalkAide System in the rehabilitation of stroke survivors.

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Naomi Clay allows following entities to bill medicare on her behalf.

Provider Name	Northampton Vision Specialists Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1801324462 PECOS PAC ID: 0345519740 Enrollment ID: O20170628000815

News Archive

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Provider Name	Aeg Massachusetts Professional Pc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1952035040 PECOS PAC ID: 6901282557 Enrollment ID: O20221005000141

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Naomi Clay is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Naomi Clay, OD 2075 S Willow St, Manchester, NH 03103-2305 Ph: () -	Dr Naomi Clay, OD 2075 S Willow St, Manchester, NH 03103-2305 Ph: (603) 644-6100

News Archive

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Optometrist in Manchester, NH

Marguerite Cote Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 254 Beech St, Manchester, NH 03103 Phone: 603-669-2043 Fax: 603-623-1686
Dr. Alison Loranger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 764 2nd St, Manchester, NH 03102 Phone: 603-669-3925 Fax: 603-669-0380
Michael Meegan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 581 2nd St Ste M, Manchester, NH 03102 Phone: 603-668-2010
Dr. Guy Lessard, O,D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 345 S Willow St, Manchester, NH 03103 Phone: 603-625-1774 Fax: 603-624-1530
Dr. Anthony Fusco & Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6 March Ave, Manchester, NH 03103 Phone: 603-647-8247 Fax: 603-898-1534
Dr. Michael Brian Nolen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Willow St, Sears Optical, Manchester, NH 03103 Phone: 603-624-8363 Fax: 603-628-5266
Dr. Denis Roger Allard, OD Optometrist Medicare: Medicare Enrolled Practice Location: 25 Bay St, Manchester, NH 03104 Phone: 603-622-1731 Fax: 603-668-3843

Dr Naomi Clay, OD - Medicare Optometrist in Manchester, NH

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Medicare Reassignments

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Simple and efficient method for creation of novel protein functions in an existing protein scaffold

Metamark Genetics closes $22M Series B financing

Advocacy groups unite to make lung cancer in women a top priority

Enrollment complete in Hanger's WalkAide System clinical trial for stroke

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Optometrist in Manchester, NH